Key result
Baseline urinary KIM-1 fails to predict cardiorenal syndrome type 1 in ADHF.
Why the study?
The study aimed to evaluate the prediction of cardiorenal syndrome type 1 by measuring kidney injury molecule-1 (KIM-1) and to establish early diagnosis of acute kidney injury in acute decompensated heart failure patients.
Does urinary KIM-1 level predict the development of cardiorenal syndrome type 1 in patients with acute decompensated heart failure after diuretic treatment?
Cohort (n=146)
No
Does urinary KIM-1 level predict the development of cardiorenal syndrome type 1 in patients with acute decompensated heart failure after diuretic treatment?
Absolute Event Rate: 2.16% vs 1.98%
p-value: p=0.117
Urinary KIM-1 levels do not appear to be a useful prognostic indicator for the development of cardiorenal syndrome type 1 or mortality in patients with acute decompensated heart failure undergoing diuretic treatment.
May aid early CRS type 1 prediction in acute HF; leaves open clinical use pending prospective validation.
Introduction Cardiorenal syndrome (CRS) is defined as acute or chronic dysfunction in the heart and kidney due to important interactions between the heart and kidney disease. The aim of this study was to evaluate prediction of CRS type 1 by measuring kidney injury molecule-1 (KIM-1) and to establish early diagnosis of acute kidney injury (AKI). Material and methods During 2015–2016, 146 patients who were admitted to the emergency service with acute decompensated HF were included in the study. We investigated urinary KIM-1 levels in 146 consecutive patients with decompensated heart failure before and after diuretic treatment. Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS – version 21.0)/Windows Statistical Software. P-values less than < 0.05 were considered significant. Results There was a moderate negative correlation between the percentage change of creatinine values and the percentage change of KIM-1 values (r = –0.357, p = 0.016). There was no statistically significant relationship between KIM-1 and the development of CRS type 1 (p = 0.011). Conclusions No statistically significant relationship was observed between KIM-1 levels and the development of CRS type 1. In addition, there was no correlation between mortality in patients and KIM-1 values. It is thought that KIM-1 is not a potential prognostic indicator because renal tubular damage is only one of many factors in the pathophysiology of CRS type 1 and heart failure.
No takes yet. Share an insight, caveat, or question.
Atıcı et al. (2019) conducted a cohort in Acute decompensated heart failure (n=146). Urinary kidney injury molecule-1 (KIM-1) vs. Patients without acute kidney injury was evaluated on Development of cardiorenal syndrome type 1 (acute kidney injury) (p=0.117). Baseline urinary kidney injury molecule-1 (KIM-1) levels did not significantly predict the development of cardiorenal syndrome type 1 in patients with acute decompensated heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: